Rchr
J-GLOBAL ID:202101019017975710   Update date: Aug. 24, 2024

Ohsugi Haruyuki

オオスギ ハルユキ | Ohsugi Haruyuki
Affiliation and department:
Research keywords  (1): 腎細胞癌
Research theme for competitive and other funds  (2):
  • 2024 - 2027 Elucidation of the metastatic and progressive mechanisms of pheochromocytoma and paraganglioma using disease-specific induced pluripotent stem cells
  • 2020 - 2024 Identification of biomarkers for precision medicine in patients with clear cell renal cell carcinoma
Papers (33):
  • Haruyuki Ohsugi, Junichi Ikeda, Kenta Takayasu, Nae Takizawa, Hisanori Taniguchi, Masaaki Yanishi, Hidefumi Kinoshita. Trifecta outcomes of robotic partial nephrectomy in obese patients: A comparison of body mass index <25, 25 to <30, and ≥30. International journal of urology : official journal of the Japanese Urological Association. 2024
  • Chisato Ohe, Takashi Yoshida, Mahul B Amin, Naho Atsumi, Junichi Ikeda, Kazuho Saiga, Yuri Noda, Yoshiki Yasukochi, Riuko Ohashi, Haruyuki Ohsugi, et al. Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2022. 35. 6. 816-824
  • Chisato Ohe, Takashi Yoshida, Mahul B Amin, Naho Atsumi, Junichi Ikeda, Kazuho Saiga, Yuri Noda, Yoshiki Yasukochi, Riuko Ohashi, Haruyuki Ohsugi, et al. Correction to: Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2022. 35. 5. 708-708
  • Kazuho Saiga, Chisato Ohe, Takashi Yoshida, Haruyuki Ohsugi, Junichi Ikeda, Naho Atsumi, Yuri Noda, Yoshiki Yasukochi, Koichiro Higasa, Hisanori Taniguchi, et al. PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma. Cancers. 2022. 14. 4
  • Chisato Ohe, Takashi Yoshida, Junichi Ikeda, Toyonori Tsuzuki, Riuko Ohashi, Haruyuki Ohsugi, Naho Atsumi, Ryosuke Yamaka, Ryoichi Saito, Yoshiki Yasukochi, et al. Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes. Biomedicines. 2022. 10. 2
more...
MISC (97):
  • 滝澤 奈恵, 元木 佑典, 大杉 治之, 木下 秀文. 魅力的な内分泌外科にするために : 泌尿器科での取り組み-To make Endocrine Surgery more attractive : Initiatives in each field (Urology)-特集 内分泌外科学会の未来に向けて今何が必要か. 日本内分泌外科学会雑誌 = Official journal of the Japan Association of Endocrine Surgeons / 日本内分泌外科学会雑誌編集部 編. 2022. 39. 4. 233-237
  • 元木 佑典, 滝澤 奈恵, 大杉 治之, 木下 秀文. 両側副腎皮質大結節性過形成primary bilateral macronodular adrenal hyperplasia (PBMAH)のマネージメント-Management of primary bilateral macronodular adrenal hyperplasia (PBMAH)-特集 両側副腎病変のマネージメント. 日本内分泌外科学会雑誌 = Official journal of the Japan Association of Endocrine Surgeons / 日本内分泌外科学会雑誌編集部 編. 2022. 39. 4. 245-249
  • 松下 純, 滝澤 奈恵, 谷口 久哲, 奥 雄太郎, 秋山 恭二朗, 天野 賢士, 川西 誠, 中尾 一慶, 吉田 崇, 池田 純一, et al. 虚血性持続勃起症に対して4回の脱血と洗浄、2回のT-shunt法を施行した1例. 日本生殖医学会雑誌. 2021. 66. 3. 115-115
  • 吉田 崇, 大江 知里, 池田 純一, 谷口 久哲, 大杉 治之, 杉 素彦, 木下 秀文, 松田 公志. 日本人における、淡明腎細胞癌に対するClearCode34 Molecular subtypesの有用性. 泌尿器科紀要. 2021. 67. 6. 249-249
  • 神尾 絵里, 吉田 崇, 大杉 治之, 杉 素彦, 木下 秀文, 松田 公志, 大江 知里. 限局性腎癌におけるGeriatric nutritio-nal risk index(GNRI)の術前予後予測因子としての有用性の検討. 泌尿器科紀要. 2021. 67. 6. 249-250
more...
Work history (7):
  • 2023/04 - 現在 Kansai Medical University
  • 2021/04 - 現在 Saiseikai Izuo Hospital
  • 2018/04 - 2021/03 Kansai Medical University Hospital
  • 2014/04 - 2018/03 Kansai Medical University Stem cell pathology
  • 2012/04 - 2014/03 Kyoto Medical Center
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page